Companies ask FDA for regulation, improvement of data collection from digital health devices
The FDA should consider regulating how data gathered from digital health devices like continuous glucose monitors and sensors are incorporated into clinical-trial submissions,
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.